UPDATE: Quidel Wins FDA Clearance for Sofia (R) Strep A Fluorescent
June 20, 2013 at 15:01 PM EDT
Quidel Corporation (NASDAQ: QDEL ), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Sofia Strep A fluorescent immunoassay for use on the Sofia Analyzer for the rapid, objective detection
